Purchase by Gregory Duncan of 25000 shares of Virios Therapeutics

Under 67% of VIRI Old's investor base is looking to short. The analysis of current outlook of investing in VIRI Old suggests that many traders are alarmed regarding VIRI Old's prospects. VIRI Old's investing sentiment shows overall attitude of investors towards VIRI Old.
  
Filed transaction by Virios Therapeutics Inc director. General open market or private purchase of non-derivative or derivative security

Read at macroaxis.com
Virios insider trading alert for perchase of common stock by Gregory Duncan, CHIEF EXECUTIVE OFFICER, on 18th of August 2023. This event was filed by Virios Therapeutics Inc with SEC on 2023-08-18. Statement of changes in beneficial ownership - SEC Form 4

VIRI Old Fundamental Analysis

We analyze VIRI Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VIRI Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VIRI Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Number Of Employees

Number Of Employees Comparative Analysis

VIRI Old is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

VIRI Old Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with VIRI Old stock to make a market-neutral strategy. Peer analysis of VIRI Old could also be used in its relative valuation, which is a method of valuing VIRI Old by comparing valuation metrics with similar companies.

Peers

VIRI Old Related Equities

RNAZTranscode Therapeutics   7.85   
0%
100.0%
REVBRevelation Biosciences   3.59   
0%
45.0%
ZVSAZyVersa Therapeutics   3.27   
0%
41.0%
ICULMF Acquisition   0.78   
0%
9.0%
CNSPCns Pharmaceuticals   0.78   
9.0%
0%
IMMXImmix Biopharma   1.42   
18.0%
0%
PHIOPhio Pharmaceuticals   3.28   
41.0%
0%
SONNSonnet Biotherapeutics   4.62   
58.0%
0%
ZURAZura Bio   4.63   
58.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Consideration for investing in VIRI Stock

If you are still planning to invest in VIRI Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VIRI Old's history and understand the potential risks before investing.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like